Antibiotics cure anthrax in animal models.

Area of Science:

• Infectious Diseases
• Microbiology
• Immunology

Background:

• Respiratory anthrax, caused by Bacillus anthracis, is typically fatal without prompt antibiotic intervention.
• Understanding the efficacy of different therapeutic strategies is critical for managing anthrax outbreaks.

Purpose of the Study:

• To evaluate the effectiveness of antibiotic therapy alone and in combination with other treatments for respiratory anthrax.
• To determine the therapeutic window for antibiotic treatment in infected animals.

Main Methods:

• Guinea pigs and rabbits were infected with Bacillus anthracis spores and treated with various antibiotics (doxycycline, ofloxacin, imipenem, gentamicin) at different time points post-infection.
• Combined treatments included antibiotics with active vaccination or anti-protective antigen (PA) antibodies.
• Bacteremia levels and survival rates were monitored.

Main Results:

• Antibiotics alone provided protection when given as postexposure prophylaxis but failed upon treatment cessation.
• Combined antibiotic and vaccine therapy resulted in full protection.
• Antibiotics combined with anti-PA antibodies significantly increased cure rates in animals with high bacteremia.
• A therapeutic window of 40-48 hours post-infection for effective antibiotic-mediated cure was observed.

Conclusions:

• Antibiotic treatment can prevent fatal disease and cure animals even after anthrax disease establishment.
• Combination therapies, particularly with anti-PA antibodies or vaccination, are more effective than antibiotics alone.
• The findings highlight a critical time window for intervention in respiratory anthrax treatment.